A team of experts in equipment and applications from Microfluidics participated in the AAPS Pharma360 2024 event, held from October 20-23 in Salt Lake City, UT. Emphasizing the latest breakthroughs in advancing global health, this incredible tradeshow showcased "new scientific ideas, theories, applications, and ways of thinking that form the basis of growth and development in different fields. Generating critical knowledge is the first step toward inventing new tools, sparking therapeutic innovation, and enabling a more rapid and successful delivery of novel drugs to the market."
High Engagement and Deep Discussions
This three-day event highlighted the growing importance of advancing pharmaceutical sciences in addressing and preventing today's most serious health concerns. Founded in 1986, the American Association of Pharmaceutical Scientists (AAPS) is composed of members in academia, industry, government, and other pharmaceutical institutes throughout the world with the common goal of enhancing global health through their initiatives.
With an array of guest speakers, posters, abstracts, and exhibition demonstrations, this annual conference brought together a diverse group of scientists to explore the achievements and challenges facing today's researchers in progressing their developments.
As the leader in laboratory and commercial processing equipment, used in the production of micro- and nano-scale materials, our Microfluidics' team was on hand to consult about our experience supporting some of the world’s top companies and universities in their drug development and pharmaceutical formulations through nanoemulsion and nanoparticle applications.
Steve Mesite, Innovation and Technology Leader
“AAPS continues to be one of the best North American tradeshows for Microfluidics. It was great to meet customers new and old in a friendly yet highly technical environment.”
Gabi Bertelli, Regional Sales Manager
“Participating at AAPS PharmSci360 consistently provides our team with invaluable insights into the latest pharmaceutical advancements. I enjoy reconnecting with so many scientists and hearing how our technology is contributing to their incredible progress.”
Chris Harvill, Applications Engineer
“I was grateful for the opportunity to attend AAPS this past week. It was incredible getting to learn from and speak to so many amazing people in the global health field. I am excited to apply this knowledge to better support our customers in addressing their drug delivery challenges.”
To learn more about our approach, contact us directly.
Related reading:
- Vaccine production systems for scalable vaccine adjuvant development
- From the lab to mass production: scaling up vaccine manufacturing
Learn more about our high shear liquid processing equipment:
